ATryn
Recombinant Human Antithrombin - ATIII
Manufacturer: GTC/Lundbeck
Generic Name:
Recombinant Human Antithroimbin- ATIII
Indications: ATryn is a recombinant antithrombin indicated for the prevention of peri-operative and peri-partum thromboembolic events in hereditary antithrombin deficient patients1.
It is not indicated for treatment of thromboembolic events in hereditary antithrombin deficient patients. |
| |
| |
| Product |
Size |
NDC Numbers |
PI |
MSDS |
| ATryn |
1750 unit vial |
67386-0521-51 |
PI |
MSDS |
| |
|
| Clinical Data:
For any questions or for
further information regarding ATryn,
recombinant antithrombin, clinical pharmacology, additional indications and
usages, contraindications,
warnings, precautions, adverse
reactions, dosage,
administration and/or storage
of this product, please
contact
BDI Pharma or call
1-800-948-9834. |
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|